1-20 of 20
Andrew Evens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The influence of age on patient-reported outcomes (PROs) endpoints on the S1826 cross-network Phase III trial of advanced-stage, classic Hodgkin lymphoma (cHL)

Free
Kelly Davison, Joseph Unger, Hongli Li, Sharon Castellino, Hildy Dillon, Tricia Hernandez, Sarah Rutherford, Angela Punnett, Michael LeBlanc, Joo Song, Sonali Smith, Andrew Evens, Kara Kelly, Jonathan Friedberg, Alex Herrera, Susan Parsons
Journal: Blood
Blood (2025) 146 (Supplement 1): 2738.
https://doi.org/10.1182/blood-2025-2738
Published: 2025
Journal Articles

External validation of the early-stage classic Hodgkin lymphoma (cHL) international prognostication index (E-HIPI) in the german Hodgkin study group (GHSG) unfavorable clinical trials

Free
Angie Mae Rodday, Dennis Eichenauer, Janina Jablonski, Sven Borchmann, Hocine Tighiouart, Jenica Upshaw, David Hodgson, Matthew Maurer, Nicholas Counsell, Sara Rossetti, Zhu Cui, Ranjana Advani, Marc Andre, Massimo Federico, Annette Hay, Richard Hoppe, Martin Hutchings, Peter Johnson, Brian Link, Eric Mou, Kerry Savage, John Radford, James Cerhan, Peter Borchmann, Andrew Evens, Susan Parsons
Journal: Blood
Blood (2025) 146 (Supplement 1): 1845.
https://doi.org/10.1182/blood-2025-1845
Published: 2025
Journal Articles

Consolidation (Cons) and maintenance (Maint) approaches in primary central nervous system lymphoma (PCNSL) after high-dose methotrexate induction in transplant-ineligible patients

Free
Yun Kyoung Tiger, Charlotte Zuber, Venkata Preetam Sandeep Kaduluri, Taylor Kujawa, Mollie Reese, Joseph Lukowski, Matthew Gromowsky, Maun Baral, Graham Wehmeyer, Joshua Friedman, Vidiya Srikakulapu, Ross Terada, Mia Willingham, Benjamin Hane, Youssef Youssef, Michele Stanchina, Juan Alderuccio, Timothy Voorhees, Joseph Bennett, Marc Hoffmann, Thomas Ollila, Praveen Ramakrishnan Geethakumari, Adam Kittai, Dilan Patel, Christopher D'Angelo, Chris Dittus, Narendranath Epperla, Cole Sterling, Andrew Evens, Matthew Matasar, Adam Olszewski
Journal: Blood
Blood (2025) 146 (Supplement 1): 3671.
https://doi.org/10.1182/blood-2025-3671
Published: 2025
Journal Articles

The use and safety of peripheral intravenous catheters (PIV) vs central venous catheters (CVC) for lymphoma patients receiving frontline anthracycline-based chemotherapy: A large multicenter real-world analysis (RWA)

Free
Yun Kyoung Tiger, Patrick Glennan, Adrienne Nedved, Joseph Lukowski, Abdus-Samad Minhaj, Alexander Sanjurjo, Melinda Harbhajan, Jacqueline Norrell, Salmaan Mubeen, Frederique St-Pierre, Gabriel Kindl, Keem Patel, Olutobi Adewale, Harris Allen, Sophia Luyten, Srilatha Dasari, Zulfa Omer, Peter Martin, Seda Tolu, Carla Casulo, Matthew Lunning, Grzegorz Nowakowski, Andrew Evens
Journal: Blood
Blood (2025) 146 (Supplement 1): 518.
https://doi.org/10.1182/blood-2025-518
Published: 2025
Journal Articles

PET-adaptive beacopp- versus ABVD-based therapies for advanced-stage (AS) classic Hodgkin lymphoma (cHL): Survival comparisons leveraging a multi-state model and analyzing the impact of a-hipi scores across the disease course

Free
Zhu Cui, Angie Mae Rodday, Hocine Tighiouart, Nicholas Counsell, Sara Rossetti, Jenica Upshaw, Amy Kirkwood, Hongli Li, Ranjana Advani, Olivier Casasnovas, James Cerhan, Massimo Federico, Andrea Gallamini, Herve Ghesquieres, Eliza Hawkes, David Hodgson, Martin Hutchings, Peter Johnson, Brian Link, Eric Mou, John Radford, Kerry Savage, Deborah Stephens, Pier Luigi Zinzani, Matthew Maurer, Cedric Rossi, Andrew Evens, Susan Parsons
Journal: Blood
Blood (2025) 146 (Supplement 1): 129.
https://doi.org/10.1182/blood-2025-129
Published: 2025
Journal Articles

Interim and end-of-treatment FDG-PET demonstrate limited ability to predict 3-year progression-free survival with nivolumab-AVD in first-line treatment of advanced stage Hodgkin lymphoma: Imaging sub-analysis of Phase 3 S1826 study

Free
Nancy Bartlett, Hongli Li, Michael Knopp, Chad Wright, Heiko Schoder, Lawrence Schwartz, Sharon Castellino, Sarah Rutherford, Andrew Evens, Kelly Davison, Angela Punnett, Margaret Shipp, Brad Kahl, John Leonard, Sonali Smith, Joo Song, Lale Kostakoglu, Kara Kelly, Michael LeBlanc, Jonathan Friedberg, Alex Herrera
Journal: Blood
Blood (2025) 146 (Supplement 1): 1851.
https://doi.org/10.1182/blood-2025-1851
Published: 2025
Journal Articles

Clinical prognostication in the SWOG 1826 randomized clinical trial of nivolumab-AVD versus brentuximab-AVD: Performance of the advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI)

Free
Carla Casulo, Hongli Li, Alex Herrera, Sharon Castellino, Sarah Rutherford, Kelly Davison, Angela Punnett, Brad Kahl, John Leonard, Sonali Smith, Joo Song, Kara Kelly, Jonathan Friedberg, Michael Leblanc, Susan Parsons, Angie Mae Rodday, Andrew Evens
Journal: Blood
Blood (2025) 146 (Supplement 1): 154.
https://doi.org/10.1182/blood-2025-154
Published: 2025
Journal Articles

3-year follow-up of the S1826 study confirms improved progression-free survival with nivolumab-AVD compared to brentuximab vedotin-AVD in advanced stage classic Hodgkin lymphoma

Free
Alex Herrera, Michael Leblanc, Sharon Castellino, Hongli Li, Sarah Rutherford, Andrew Evens, Kelly Davison, Susan Parsons, Sairah Ahmed, Carla Casulo, Nancy Bartlett, Joseph Tuscano, Matthew Mei, Brian Hess, Ryan Jacobs, Boyu Hu, Craig Moskowitz, Christopher Forlenza, Andrew Doan, Adam Lamble, David Hodgson, Anca Prica, Michael Knopp, Tricia Hernandez, Richard Little, Margaret Shipp, Michael Crump, Brad Kahl, John Leonard, Sonali Smith, Joo Song, Kara Kelly, Jonathan Friedberg
Journal: Blood
Blood (2025) 146 (Supplement 1): 151.
https://doi.org/10.1182/blood-2025-151
Published: 2025
Journal Articles

Novel immune gene expression signature risk-stratifies Mantle Cell Lymphoma outcomes independent of TP53 status

Free
Jean Koff, Veronica Russell, Rachel Kositsky, David Jaye, Michael Churnetski, Katelin Baird, Colin O'Leary, Christopher Flowers, Sirpa Leppä, Shaoying Li, Jessie Xu, Mette Pedersen, Anne Ortved Gang, Kikkeri N Naresh, Rex Au-Yeung, Jennifer Chapman, Amy Chadburn, Izidore S. Lossos, Sarah Ondrejka, Abner Louissaint, Eric Tse, Cassandra Love, Devang Thakkar, Clayton Parker, Choon Kiat Ong, Andrew Evans, Emily F. Mason, Yan Jiong, Magdalena Czader, Andrew Evens, Dina Soliman, Yuri Fedoriw, Sandeep Dave, Jonathon Cohen
Journal: Blood
Blood (2025) 146 (Supplement 1): 352.
https://doi.org/10.1182/blood-2025-352
Published: 2025
Journal Articles

Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826

Free
Julia Paczkowska, Marcin Kaszkowiak, Michael Leblanc, Chip Stewart, Alex Herrera, Juan Carlos Fernandez del Castillo, Sharon Castellino, Sarah Rutherford, Andrew Evens, Kelly Davison, Hongli Li, Donna Neuberg, Mark Murakami, Jasmine Makker, Brad Kahl, John Leonard, Nancy Bartlett, Sonali Smith, Joo Song, Kara Kelly, Gad Getz, Jonathan Friedberg, Margaret Shipp
Journal: Blood
Blood (2025) 146 (Supplement 1): 351.
https://doi.org/10.1182/blood-2025-351
Published: 2025
Journal Articles

Patient-Derived Xenografts (PDX) of B Cell Lymphoma in NSG Mice: A Mouse Avatar for Developing Personalized Medicine

Free
Rachel Gerstein, PhD, Zheng Zhou, MD PhD, Hong Zhang, PhD, Andrew Evens, DO, MSc, FACP, Nicole Walsh, PhD, Leonard Shultz, Rita Bortell, PhD, Michael Brehm, PhD, Jan Cerny, MD PhD, Giles Whalen, MD, Jack Leonard, PhD, Bruce Woda, MD, Dale Greiner, PhD, Alan G. Rosmarin, MD
Journal: Blood
Blood (2015) 126 (23): 5408.
https://doi.org/10.1182/blood.V126.23.5408.5408
Published: 2015
Journal Articles

Outcome of Relapse after Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) - The Effect of the Underlying Disease on Survival Following Relapse.

Free
Seema Singhal, Olga Frankfurt, Andrew Evens, Leo Gordon, Martin Tallman, Stephanie Williams, Jane Winter, David Grinblatt, Lynne Kaminer, Jayesh Mehta
Journal: Blood
Blood (2007) 110 (11): 5020.
https://doi.org/10.1182/blood.V110.11.5020.5020
Published: 2007
Journal Articles

Tacrolimus Dosing in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients Receiving Concomitant Voriconazole.

Free
Steven Trifilio, Judy Pi, Seema Singhal, Olga Frankfurt, Andrew Evens, Leo Gordon, Martin Tallman, Jane Winter, Stephanie Williams, Jayesh Mehta
Journal: Blood
Blood (2007) 110 (11): 4956.
https://doi.org/10.1182/blood.V110.11.4956.4956
Published: 2007
Journal Articles

Breakthrough Fungal Infections after Allogeneic Hematopoietic Stem Cell Transplantation in Patients on Prophylactic Voriconazole.

Free
Steve Trifilio, Seema Singhal, Stephanie Williams, Jane Winter, Martin Tallman, Leo Gordon, Olga Frankfurt, Andrew Evens, Jayesh Mehta
Journal: Blood
Blood (2006) 108 (11): 2849.
https://doi.org/10.1182/blood.V108.11.2849.2849
Published: 2006
Journal Articles

Submyeloablative Allogeneic HSCT for Hematologic Malignancies: Effect of Body Weight.

Free
Seema Singhal, Leo Gordon, Martin Tallman, Jane Winter, Stephanie Williams, Olga Frankfurt, Andrew Evens, Richard Meagher, Lynne Kaminer, David Grinblatt, Jayesh Mehta
Journal: Blood
Blood (2006) 108 (11): 2949.
https://doi.org/10.1182/blood.V108.11.2949.2949
Published: 2006
Journal Articles

90 Y Ibritumomab Tiuxetan (Zevalin®; 90 YZ) Doses Calculated To Deliver up to 1500 cGy to Critical Organs May Be Safely Combined with High-Dose BEAM and Autotransplant in NHL.

Free
Jane N. Winter, MD, David Inwards, M.D., Stewart Spies, M.D., Gregory Wiseman, M.D., David Patton, B.S., William Erwin, M.S., Alfred Rademaker, Ph.D., Stephanie Williams, M.D., Martin S. Tallman, M.D., Ivana Micallef, M.D., Jayesh Mehta, M.D., Seema Singhal, M.D., Andrew Evens, D.O., Michael Zimmer, Ph.D., Arturo Molina, M.D., Christine White, M.D., Leo I. Gordon, M.D.
Journal: Blood
Blood (2006) 108 (11): 330.
https://doi.org/10.1182/blood.V108.11.330.330
Published: 2006
Journal Articles

Submyeloablative Allografts for Hematologic Malignancies: Validation of a Prognostic Model Based on Pre-Transplant Variables.

Free
Jayesh Mehta, Jane Winter, Martin Tallman, Leo Gordon, Stephanie Williams, Olga Frankfurt, Andrew Evens, David Grinblatt, Lynne Kaminer, Richard Meagher, Seema Singhal
Journal: Blood
Blood (2006) 108 (11): 3036.
https://doi.org/10.1182/blood.V108.11.3036.3036
Published: 2006
Journal Articles

Reduced-Intesity Allogeneic HSCT in Hematologic Malignancies: Influence of Underlying Diagnosis and Prior Autograft on Outcome.

Free
Jayesh Mehta, Leo Gordon, Martin Tallman, Jane Winter, Stephanie Williams, Olga Frankfurt, Andrew Evens, David Grinblatt, Lynne Kaminer, Richard Meagher, Kamran Rashid, Donna Grabowski, Seema Singhal
Journal: Blood
Blood (2006) 108 (11): 3040.
https://doi.org/10.1182/blood.V108.11.3040.3040
Published: 2006
Journal Articles

Motexafin Gadolinium (MGd) Has Clinical Activity in Relapsed/Refractory Low Grade Lymphomas (LG) and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).

Free
Brad S. Kahl, MD, Ranjana Advani, MD, Neil Kay, MD, Izidore S. Lossos, MD, Andrew Evens, DO, Leo Gordon, MD, Richard A. Miller, MD, See-Chun Phan, MD
Journal: Blood
Blood (2005) 106 (11): 4758.
https://doi.org/10.1182/blood.V106.11.4758.4758
Published: 2005
Journal Articles

Comparison of Out-of-Pocket Costs for Patients (pts) with Hodgkin’s Disease (HD), Indolent Non-Hodgkin’s Lymphoma (INHL) and Aggressive Non-Hodgkin’s Lymphoma (ANHL).

Free
Kathryn McCaffrey, BA, Matthew Fisher, Lucie Kutikova, PhD, Lee Bowman, PhD, Andrew Evens, DO, Leo Gordon, MD, Heather Auto, Charles Bennett, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2241.
https://doi.org/10.1182/blood.V106.11.2241.2241
Published: 2005